These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19409169)

  • 1. Designer orthopaedic surgery in a patient with anti-Vel antibodies.
    Syed S; Bhatti A; Shah MM
    J Coll Physicians Surg Pak; 2009 May; 19(5):321-2. PubMed ID: 19409169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients with anti-Vel--immunohematological characterization and transfusion management.
    Lynen R; Simson G; Quentin SH; Schulte B; The LG; Neumeyer H
    Beitr Infusionsther; 1990; 26():377-9. PubMed ID: 1703877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are you overlooking shoulder surgery?
    Johns Hopkins Med Lett Health After 50; 2007 Sep; 19(7):3, 7. PubMed ID: 18229400
    [No Abstract]   [Full Text] [Related]  

  • 4. Shoulder replacement: better than it sounds. Shoulder surgery is less risky than hip or knee replacement.
    Duke Med Health News; 2007 Jul; 13(7):1, 11. PubMed ID: 17687787
    [No Abstract]   [Full Text] [Related]  

  • 5. [Transfusion policy toward a patient with an anti-Cartwright antibody (anti-Yta)].
    Arriaga F; García R; Guinot M; de la Rubia J; García M; Bonanad S; Marty ML
    Sangre (Barc); 1993 Aug; 38(4):327-9. PubMed ID: 8235948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful transfusion of a patient with Anti-Yka.
    Ryden SE
    Transfusion; 1981; 21(1):130-1. PubMed ID: 7466902
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of acute normovolaemic haemodilution on blood gas parameters: a case report.
    Erol DD; Erdogan Y
    Adv Ther; 2008 Feb; 25(2):148-51. PubMed ID: 18311548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-Tja antibody as a transfusion problem in surgery with a high risk of bleeding].
    Barbolla L; Campano F; Cabrera P; Zabala P; Sanjuan I; Fernández MN
    Sangre (Barc); 1987; 32(6):731-4. PubMed ID: 3438811
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of emergency cardiac surgery in a patient with alloanti-Ge2.
    Selleng S; Selleng K; Zawadzinski C; Wollert HG; Yürek S; Greinacher A
    Transfus Med; 2009 Feb; 19(1):50-2. PubMed ID: 19302455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glenohumeral arthritis in the young patient.
    Chong PY; Srikumaran U; Kuye IO; Warner JJ
    J Shoulder Elbow Surg; 2011 Mar; 20(2 Suppl):S30-40. PubMed ID: 21281920
    [No Abstract]   [Full Text] [Related]  

  • 11. Haemolytic disease of the newborn because of rare anti-Vel.
    van Gammeren AJ; Overbeeke MA; Idema RN; van Beek RH; Ten Kate-Booij MJ; Ermens AA
    Transfus Med; 2008 Jun; 18(3):197-8. PubMed ID: 18598283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequently encountered problems in transfusion medicine when managing patients with antibodies.
    Neurath D; Moulds J
    Transfus Apher Sci; 2009 Jun; 40(3):183-4. PubMed ID: 19409849
    [No Abstract]   [Full Text] [Related]  

  • 13. Is a computer crossmatch in the absence of an immediate-spin antibody screen adequate for persons identified to be at increased risk of forming new blood group antibodies?
    Sandler SG; Abedalthagafi M; Langeberg A
    Transfusion; 2008 Oct; 48(10):2265-6. PubMed ID: 18928510
    [No Abstract]   [Full Text] [Related]  

  • 14. Allograft total ankle replacement--a dead ringer to the natural joint.
    Jeng CL; Myerson MS
    Foot Ankle Clin; 2008 Sep; 13(3):539-47, x. PubMed ID: 18692015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemolytic disease of the fetus and newborn due to anti-Ge3: combined antibody-dependent hemolysis and erythroid precursor cell growth inhibition.
    Blackall DP; Pesek GD; Montgomery MM; Oza KK; Arndt PA; Garratty G; Shahcheraghi A; Denomme GA
    Am J Perinatol; 2008 Oct; 25(9):541-5. PubMed ID: 18720327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common and frequently encountered antibodies.
    Hamilton JR
    Transfus Apher Sci; 2009 Jun; 40(3):189-94. PubMed ID: 19409850
    [No Abstract]   [Full Text] [Related]  

  • 17. Red blood cell antibodies in pregnancy and their clinical consequences: synergistic effects of multiple specificities.
    Nordvall M; Dziegiel M; Hegaard HK; Bidstrup M; Jonsbo F; Christensen B; Hedegaard M
    Transfusion; 2009 Oct; 49(10):2070-5. PubMed ID: 19497053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to high-incidence antigens.
    Moulds MK
    Transfus Apher Sci; 2009 Jun; 40(3):203-4. PubMed ID: 19409851
    [No Abstract]   [Full Text] [Related]  

  • 19. The Vel blood group system.
    Sussman LN; Pretshold H
    Haematologia (Budap); 1972; 6(1):129-33. PubMed ID: 5026468
    [No Abstract]   [Full Text] [Related]  

  • 20. Clearance of erythrocyte allo-antibodies using Rituximab.
    Gryn J; Zeigler ZR; Shadduck RK; Thomas C
    Bone Marrow Transplant; 2002 Apr; 29(7):631-2. PubMed ID: 11979318
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.